Entrepreneur Universe Bright Group (EUBG)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	546	536	680	396	823	14
Market Cap Growth	8.07%	-21.25%	72.04%	-51.95%	5592.94%	431.25%
Enterprise Value	537	528	672	389	816	14
Last Close Price	0.32	0.32	0.40	0.23	0.48	0.01
PE Ratio	420.83	360.22	298.14	977.53	757.73	2.91
PS Ratio	109.73	101.60	109.07	112.76	146.03	1.57
PB Ratio	63.54	63.73	74.52	57.45	121.75	2.60
P/TBV Ratio	63.54	63.73	74.52	57.45	121.75	2.60
P/FCF Ratio	-	393.87	292.89	-	1822.60	2.37
P/OCF Ratio	399.00	393.87	292.66	-	1822.60	2.23
EV/Sales Ratio	107.96	100.05	107.68	110.98	144.68	1.53
EV/EBITDA Ratio	231.44	200.53	170.39	323.77	413.78	1.89
EV/EBIT Ratio	240.49	204.40	173.87	347.44	432.02	1.90
EV/FCF Ratio	-	387.85	289.15	-	1805.80	2.30
Debt / Equity Ratio	0.01	0.01	0.00	0.04	0.02	0.03
Debt / EBITDA Ratio	0.04	0.04	0.01	0.20	0.07	0.02
Debt / FCF Ratio	0.08	0.09	0.01	-	0.33	0.03
Asset Turnover	0.50	0.54	0.70	0.44	0.71	2.14
Quick Ratio	16.73	14.25	11.77	10.81	7.66	2.66
Current Ratio	16.85	14.40	11.84	10.89	7.70	4.81
Return on Equity (ROE)	14.39%	16.96%	28.50%	5.93%	17.62%	170.02%
Return on Assets (ROA)	14.12%	16.51%	26.93%	8.77%	14.82%	107.96%
Return on Capital (ROIC)	15.38%	18.24%	29.63%	9.97%	18.67%	154.12%
Return on Capital Employed (ROCE)	25.10%	29.50%	41.50%	15.80%	26.30%	119.40%
Earnings Yield	0.24%	0.28%	0.34%	0.10%	0.13%	34.36%
FCF Yield	-	0.25%	0.34%	-0.04%	0.06%	42.29%
Payout Ratio	170.60%	148.66%	-	-	-	-
Buyback Yield / Dilution	-	-	-	-	-	-52.70%

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.